A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia

被引:62
作者
Hayashi, J [1 ]
Furusyo, N [1 ]
Ariyama, I [1 ]
Sawayama, Y [1 ]
Etoh, Y [1 ]
Kashiwagi, S [1 ]
机构
[1] Kyushu Univ Hosp, Dept Gen Med, Higashi Ku, Fukuoka 8128582, Japan
关键词
D O I
10.1086/315431
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To clarify the mechanism of Liver damage induced by hepatitis C virus (HCV) and to determine whether the damage is related to hepatocellular carcinoma (HCC), HCV RNA levels were measured serially, and HCV genome mutations were analyzed from serum of 274 Japanese patients with chronic HCV viremia during 1993-1998, All patients had alanine aminotransferase (ALT) levels measured during 1986-1998, Patients with consistently normal ALT levels had identical and highly conserved HCV core regions; however, those with consistently abnormal ALT levels had quasi species, and the population of the quasi species changed over time, HCV RNA levels did not change in the 274 patients. HCC developed in 31% of 80 patients with consistently abnormal ALT levels and in 4% of 92 patients with intermittently abnormal ALT levels but never in 102 patients with ALT levels consistently normal during 1993-1998. In patients with chronic HCV viremia, persistent liver damage plays an important role in the development of HCC.
引用
收藏
页码:1523 / 1527
页数:5
相关论文
共 28 条
[1]   HEPATITIS-C VIREMIA AND LIVER-DISEASE IN SYMPTOM-FREE INDIVIDUALS WITH ANTI-HCV [J].
ALBERTI, A ;
MORSICA, G ;
CHEMELLO, L ;
CAVALLETTO, D ;
NOVENTA, F ;
PONTISSO, P ;
RUOL, A .
LANCET, 1992, 340 (8821) :697-698
[2]   CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HEPATITIS-C VIRUS-DERIVED PEPTIDES CONTAINING THE HLA A2.1 BINDING MOTIF [J].
CERNY, A ;
MCHUTCHISON, JG ;
PASQUINELLI, C ;
BROWN, ME ;
BROTHERS, MA ;
GRABSCHEID, B ;
FOWLER, P ;
HOUGHTON, M ;
CHISARI, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (02) :521-530
[3]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[4]  
COLOMBO M, 1989, LANCET, V2, P1006
[5]   HCV-ASSOCIATED LIVER-CANCER WITHOUT CIRRHOSIS [J].
DEMITRI, MS ;
POUSSIN, K ;
BACCARINI, P ;
PONTISSO, P ;
DERRICO, A ;
SIMON, N ;
GRIGIONI, W ;
ALBERTI, A ;
BEAUGRAND, M ;
PISI, E ;
BRECHOT, C ;
PATERLINI, P .
LANCET, 1995, 345 (8947) :413-415
[6]  
DIENES HP, 1982, HEPATOLOGY, V2, P562
[7]   Hepatitis C virus-associated fulminant hepatic failure [J].
Farci, P ;
Alter, HJ ;
Shimoda, A ;
Govindarajan, S ;
Cheung, LC ;
Melpolder, JC ;
Sacher, RA ;
Shih, JW ;
Purcell, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :631-634
[8]   Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: A prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection [J].
Furusyo, N ;
Hayashi, J ;
Sawayama, Y ;
Kishihara, Y ;
Kashiwagi, S .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 60 (04) :616-622
[9]  
GORDON SC, 1994, AM J GASTROENTEROL, V89, P1458
[10]   QUANTITATIVE-ANALYSIS OF HEPATITIS-C VIRUS-RNA IN SERUM DURING INTERFERON ALFA THERAPY [J].
HAGIWARA, H ;
HAYASHI, N ;
MITA, E ;
TAKEHARA, T ;
KASAHARA, A ;
FUSAMOTO, H ;
KAMADA, T .
GASTROENTEROLOGY, 1993, 104 (03) :877-883